Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease
BackgroundBiomarker screening is of major significance for the early diagnosis and prevention of Alzheimer’s disease (AD). Routine peripheral blood parameters are easy to collect and detect, making them ideal potential biomarkers. Thus, we aimed to evaluate the parameters from routine blood as poten...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2019.00332/full |
id |
doaj-3c929667435c4535b4729ff9dd746b06 |
---|---|
record_format |
Article |
spelling |
doaj-3c929667435c4535b4729ff9dd746b062020-11-25T02:20:09ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652019-12-011110.3389/fnagi.2019.00332491908Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s DiseaseXiaoyu DongJianfei NaoJile ShiDongming ZhengBackgroundBiomarker screening is of major significance for the early diagnosis and prevention of Alzheimer’s disease (AD). Routine peripheral blood parameters are easy to collect and detect, making them ideal potential biomarkers. Thus, we aimed to evaluate the parameters from routine blood as potential biomarkers for AD.MethodsWe enrolled 56 AD patients, 57 mild cognitive impairment (MCI) patients, and 59 healthy elderly controls. Receiver operating characteristic (ROC) curves were used to assess the diagnostic values of routine blood biomarkers in patients with cognitive impairment.ResultsThere were significant differences in eight parameters between the groups. Logistic regression revealed that the neutrophil% (odds ratio (OR) 1.34, 95% confidence interval [CI] 1.03–1.75, p = 0.031) and neutrophil-to-lymphocyte ratio (NLR; OR 6.27, 95% CI 3.98–9.82, p = 0.003) differentiated AD patients and controls (areas under the curve [AUCs], 0.728 and 0.721) and that the NLR (OR 1.93, 95% CI 1.07–3.47, p = 0.028) and mean platelet volume (OR 1.67, 95% CI 1.04–2.70, p = 0.036) differentiated MCI patients and controls (AUCs, 0.60 and 0.638). There were no effective diagnostic biomarkers to distinguish AD from MCI.ConclusionSome routine blood biomarkers may correlate with cognitive impairment. Analysis of these biomarkers, such as the NLR, may be useful for the identification of patients with cognitive impairment.https://www.frontiersin.org/article/10.3389/fnagi.2019.00332/fullAlzheimer diseasebiomarkersblood routinemild cognitive impairmentaging |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiaoyu Dong Jianfei Nao Jile Shi Dongming Zheng |
spellingShingle |
Xiaoyu Dong Jianfei Nao Jile Shi Dongming Zheng Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease Frontiers in Aging Neuroscience Alzheimer disease biomarkers blood routine mild cognitive impairment aging |
author_facet |
Xiaoyu Dong Jianfei Nao Jile Shi Dongming Zheng |
author_sort |
Xiaoyu Dong |
title |
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease |
title_short |
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease |
title_full |
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease |
title_fullStr |
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease |
title_full_unstemmed |
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease |
title_sort |
predictive value of routine peripheral blood biomarkers in alzheimer’s disease |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Aging Neuroscience |
issn |
1663-4365 |
publishDate |
2019-12-01 |
description |
BackgroundBiomarker screening is of major significance for the early diagnosis and prevention of Alzheimer’s disease (AD). Routine peripheral blood parameters are easy to collect and detect, making them ideal potential biomarkers. Thus, we aimed to evaluate the parameters from routine blood as potential biomarkers for AD.MethodsWe enrolled 56 AD patients, 57 mild cognitive impairment (MCI) patients, and 59 healthy elderly controls. Receiver operating characteristic (ROC) curves were used to assess the diagnostic values of routine blood biomarkers in patients with cognitive impairment.ResultsThere were significant differences in eight parameters between the groups. Logistic regression revealed that the neutrophil% (odds ratio (OR) 1.34, 95% confidence interval [CI] 1.03–1.75, p = 0.031) and neutrophil-to-lymphocyte ratio (NLR; OR 6.27, 95% CI 3.98–9.82, p = 0.003) differentiated AD patients and controls (areas under the curve [AUCs], 0.728 and 0.721) and that the NLR (OR 1.93, 95% CI 1.07–3.47, p = 0.028) and mean platelet volume (OR 1.67, 95% CI 1.04–2.70, p = 0.036) differentiated MCI patients and controls (AUCs, 0.60 and 0.638). There were no effective diagnostic biomarkers to distinguish AD from MCI.ConclusionSome routine blood biomarkers may correlate with cognitive impairment. Analysis of these biomarkers, such as the NLR, may be useful for the identification of patients with cognitive impairment. |
topic |
Alzheimer disease biomarkers blood routine mild cognitive impairment aging |
url |
https://www.frontiersin.org/article/10.3389/fnagi.2019.00332/full |
work_keys_str_mv |
AT xiaoyudong predictivevalueofroutineperipheralbloodbiomarkersinalzheimersdisease AT jianfeinao predictivevalueofroutineperipheralbloodbiomarkersinalzheimersdisease AT jileshi predictivevalueofroutineperipheralbloodbiomarkersinalzheimersdisease AT dongmingzheng predictivevalueofroutineperipheralbloodbiomarkersinalzheimersdisease |
_version_ |
1724873338756530176 |